CaitrionaRyanMDFAAD, MB, BCh, BAO, BMedSc, MRCPI

PubMed

• 2 citations
  Ixekizumab provides persistent improvements in health‐related quality of life and the sexual impact associated with moderate‐to‐severe genital psoriasis in adult patie...
  Caitriona Ryan, Lyn Guenther, Peter Foley, J. Weisman, Russel Burge
  Journal of the European Academy of Dermatology and Venereology. 2021-11-23
• 3 citations
  High Levels of Psychological Distress, Sleep Disturbance, and Alcohol Use Disorder in Adults With Atopic Dermatitis.
  Eimear Gilhooley, Ciara O'Grady, Darren Roche, Julie Mac Mahon, Roisin Hambly
  Dermatitis. 2021-10-01
• 12 citations
  Psoriasis severity: commonly used clinical thresholds may not adequately convey patient impact.
  N M Golbari, J. M. Van der Walt, Andrew Blauvelt, Caitriona Ryan, P.C.M. van de Kerkhof
  Journal of the European Academy of Dermatology and Venereology. 2021-02-01

Journal Articles

• Biologics in practice: using biologic agents in combination with methotrexate in psoriasis therapy. The Dermatologist 2014; 21: 28-31  
  Haugh I, Ryan C, Menter A., The Dermatologist, 3/2014
• Ryan C. Continuing the dialogue: the future of psoriasis.  
  Ryan C., Psoriasis Review, 12/2012
• Are drug treatments for psoriasis a cardiovascular risk? Clinical Practice 2012  
  Ryan C, Patel M, Menter A., Clinical Practice, 2012
• The use of pharmacogenomics in psoriasis. Clinical Investigation 2011  
  Ryan C, Bowcock A, Menter A., Clinical Investigation, 3/2011
• Biologic Therapies for Chronic Plaque Psoriasis and Cardiovascular Events—Reply [letter].  
  Ryan C, Daoud Y, Menter A., JAMA, 2011
• Neuropeptides and psoriasis.  
  Ryan C, Kirby B., G Ital Dermatol Venereol, 10/2007
• Join now to see all

Books/Book Chapters

• Psoriasis: Diagnosis and Management 
  Chapter: Recent and future developments in targeted therapy 
  Ryan C, Menter AEditors: Sterry W.Wiley-BlackwellEdition 1,2014
• Advances in Psoriasis 
  Chapter: Ustekinumab 
  Ryan C, Leonardi CEditors: Weinberg J.Springer2014
• Brenner's Online Encyclopedia of Genetics 
  Chapter: Psoriasis 
  Page 524 - 526Ryan C, Bowcock AM, Menter AEditors: Maloy S, Hughes Kelly.Academic PressEdition 2nd,2013

Abstracts/Posters

• Genital psoriasis is associated with significant impairment in quality of life and sexual functioning
  Ryan C, Sadlier M, Patel M, Kirby B, Menter A, International Investigative Dermatology Meeting, Edinburgh, Scotland, 3/1/2013
• Systems analysis of pneumococcal vaccine response in psoriasis patients
  Obermoser G, Ryan C, Ruchaud E, Mansouri B, Patel M, Palucka K, Menter A, International Investigative Dermatology Meeting, Edinburgh, Scotland, 3/1/2013
• Genital psoriasis is associated with significant impairment in quality of life and sexual functioning
  Ryan C, Sadlier M, Patel M, Kirby B, Menter A, J Invest Dermatol, 1/1/2013
• Systems analysis of pneumococcal vaccine response in psoriasis patients
  Obermoser G, Ryan C, Ruchaud E, Mansouri B, Patel M, Palucka K, Menter A, J Invest Dermatol, 1/1/2013
• Alterations in leukocyte subsets in the blood of psoriasis patients
  Obermoser G, Ryan C, Banchereau J, Pascual V, Chaussabel D, Menter A, Society of Investigational Dermatology Annual Meeting, Phoenix, AZ, 5/1/2011
• Antagonism of p40 cytokines in psoriasis patients may promote paradoxical cardiovascular risk; a meta-analysis of randomized controlled trials and report of a consensu...
  Ryan C, Leonardi CL, Krueger JG, Kimball AB, Strober BE, Gordon KB, Langley RG, Kaplan DH, Menter A, Annual Meeting of Society of Investigative Dermatology, Phoenix, AZ, 5/1/2011
• Antagonism of p40 cytokines in psoriasis patients may promote paradoxical cardiovascular risk; a meta-analysis of randomized controlled trials and report of a consensu...
  Ryan C, Leonardi CL, Krueger JG, Kimball AB, Strober BE, Gordon KB, Langley RG, Kaplan DH, Menter A, J Invest Dermatol, 1/1/2011
• Alterations in leukocyte subsets in the blood of psoriasis patients
  Obermoser G, Ryan C, Banchereau J, Pascual V, Chaussabel D, Menter A, J Invest Dermatol, 1/1/2011
• The use of transcriptional profiling to evaluate psoriasis as a systemic disease
  Ryan C, Obermoser G, Banchereau R, Lemoine B, Pascual V, Banchereau J, Chaussabel D, Menter A, European Association of Dermatology and Venereology Annual Meeting; Society of Investigational Dermatology Annual Meeting, Atlanta, GA, 5/1/2010
• Clinical and genetic predictors of response to narrowband UVB in the treatment of chronic plaque psoriasis
  Ryan C, Renfro L, Collins P, Kirby B, Roger S, Br J Dermatol, 1/1/2010
• The use of transcriptional profiling to evaluate psoriasis as a systemic disease
  Ryan C, Banchereau R, Obermoser G, Lemoine B, Pascual V, Banchereau J, Chaussabel D, Menter A, J Invest Dermatol, 1/1/2010
• HLA-Cw*0602 as a predictor of response to TNF inhibitors in the treatment of chronic plaque psoriasis
  Ryan C, Kirby B, British Association of Dermatology Meeting, Glasgow, Scotland, 7/1/2009
• A study to examine if the HLACw* 0602 allele is a predictor of response to TNF-a inhibitors in the treatment of psoriasis
  Ryan C, Kelleher J, Collins P, Rogers S, Kirby B, Br J Dermatol, 1/1/2009
• Treatment of acrodermatitis continua of Hallopeau with adalimumab, Psoriasis Gene to Clinic
  Ryan C, Collins P, Kirby B, Rogers S, London, England, 12/1/2008
• Treatment of acrodermatitis continua of Hallopeau with adalimumab, Psoriasis Gene to Clinic
  Ryan C, Collins P, Kirby B, Rogers S, London, England, 12/1/2008
• Adalimumab Treatment for Severe Recalcitrant Psoriasis
  Ryan C, Kirby B, Collins P, Rogers S, British Association of Dermatology Meeting, Liverpool, England, 7/1/2008
• Two years' experience with adalimumab in severe, recalcitrant psoriasis
  Ryan C, Kirby B, Collins P, Rogers S, Br J Dermatol, 1/1/2008
• Treatment of acrodermatitis continua of Hallopeau with adalimumab
  Ryan C, Collins P, Kirby B, Rogers S, Br J Dermatol, 1/1/2008
• Redefining outlook for survivors of class IV heart failure admission: Long term follow up of 536 patients in a hospital based disease management programme
  O'Loughlin C, Murphy N, Conlon C, Traynor T, Ryan C, Ledwidge M, McDonald K, Eur J Heart Fail, 1/1/2006
• Growing Awareness and Changing Trends In Prevention Of Glucocorticoid-induced Osteoporosis, 2002-2006. A Re-audit
  Mohammad A, Ryan JG, Ralph N, Ryan C, O'Connell PG, Arth+Rheum, 1/1/2006
• Diastolic and Systolic Heart failure patients derive similar benefit from a hospital based disease management program: 3 year follow up of 438 patients
  Martos R, Conlon C, O Loughlin C, Traynor C, Ryan C, Ledwidge M, Mc Donald K, Eur J Heart Fail, 1/1/2005
• Defining a new outlook for survivors of class IV heart failure admission: 3 year followup of 477 patients managed in a hospital based disease management program
  Conlon C, O'Loughlin C, Ryan C, Traynor C, Martos R, Ledwidge M, McDonald K, Eur J Heart Fail, 1/1/2005
• Join now to see all

Lectures

• “The Shifting Paradigm in Psoriasis Treatment,” 
  International Psoriasis Council Meeting, Dallas, TX - 4/10/2014
• Research Gaps in Psoriasis: Genetics and Pathophysiology 
  Denver, CO - 3/1/2014
• TNF-alpha antagonists and p40 antibodies in psoriasis: similarities and differences 
  Stockholm, Sweden - 6/1/2012
• Practical Case Management in Psoriasis 
  Dublin, Ireland - 5/1/2012
• Psoriasis; what lies beneath 
  Dublin, Ireland - 5/1/2012
• The effect of biologic treatments on cardiovascular risk in psoriasis 
  Dallas, TX - 11/1/2011
• LEO 80185-G23 Guide to Clinical Assessments 
  San Antonio, TX - 9/1/2011
• The association between biologic treatments for psoriasis and cardiovascular risk 
  London, England - 7/1/2011
• Anti-IL-12/23 agents and JAK inhibitors for the treatment of psoriasis: a review 
  Dallas, TX - 5/1/2011
• Antagonism of p40 cytokines in psoriasis patients may promote paradoxical cardiovascular risk; a meta-analysis of randomized controlled trials and report of a consensu... 
  Phoenix, AZ - 5/1/2011
• Clinical and genetic predictors of response to narrowband UVB in the treatment of chronic plaque psoriasis 
  Manchester, England - 7/1/2010
• A review of the safety profile of ustekinumab 
  Manchester, England - 7/1/2010
• The effect of narrowband ultraviolet B treatment for psoriasis on vitamin D status during wintertime in Ireland 
  Miami, FL - 3/1/2010
• Traditional systemic therapies for the treatment of psoriasis 
  Dallas, TX - 11/1/2009
• Anti-IL12/23 antibodies in the treatment of psoriasis/psoriatic arthritis 
  Dallas, TX - 11/1/2009
• CMV induced vasculopathy and perianal ulceration 
  San Francisco, CA - 3/1/2009
• Cryoglobulin associated angiomatosis 
  San Francisco, CA - 3/1/2009
• Updates in Psoriasis 
  Dublin, Ireland - 3/1/2009
• Adalimumab Treatment for Severe Recalcitrant Psoriasis 
  Dublin, Ireland - 4/1/2008
• Folliculotropic and Ichthyosiform Mycosis Fungoides 
  London, England - 12/1/2007
• Necrotising Lesions of the Male Genitalia 
  Dublin, Ireland - 9/1/2006
• Join now to see all